DCF — ASPIRUS IRONWOOD HOSPITAL
Enterprise Value: $-44.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-44.4M
Enterprise Value
$-15.4M
PV of Cash Flows
$-29.0M
PV of Terminal Value
$-46.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $67.4M | $-2.0M | -3.0% | $-4.9M | $-4.4M |
| Year 2 | $69.4M | $-1.4M | -2.0% | $-4.3M | $-3.6M |
| Year 3 | $71.5M | $-0.7M | -1.0% | $-3.8M | $-2.8M |
| Year 4 | $73.7M | $-0.4M | -1.0% | $-3.5M | $-2.4M |
| Year 5 | $75.9M | $-0.2M | -0.0% | $-3.4M | $-2.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-44.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$65.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.035240420413781
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5